πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 23 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12220420

Combination therapy for cancer treatment

Galera Labs, LLC Β· Granted Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12156863

Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound

Galera Labs, LLC Β· Granted Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12077549

Pentaaza macrocyclic ring complexes possessing oral bioavailability

Galera Labs, LLC Β· Granted Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11826373

Methods for treatment of diseases

Galera Labs, LLC Β· Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11612608

Methods of treating oral mucositis

Galera Labs, LLC Β· Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11246950

Combination cancer immunotherapy with pentaaza macrocyclic ring complex

Galera Labs, LLC Β· Granted Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11219614

Combination cancer therapy with pentaaza macrocyclic ring complex and ascorbate compound

Galera Labs, LLC Β· Granted Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11066433

Pentaaza macrocyclic ring complexes possessing oral bioavailability

Galera Labs, LLC Β· Granted Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10610533

Methods of treating oral mucositis

Galera Labs, LLC Β· Granted Tue Apr 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10597415

Pentaaza macrocyclic ring complexes possessing oral bioavailability

Galera Labs, LLC Β· Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10493081

Methods for treatment of diseases

Galera Labs, LLC Β· Granted Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10350193

Super-oxide dismutase mimetics

Galera Labs, LLC Β· Granted Tue Jul 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10137133

Methods for treatment of diseases

Galera Labs, LLC Β· Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9855279

Methods of treating oral mucositis

Galera Labs, LLC Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9738670

Pentaaza macrocyclic ring complexes possessing oral bioavailability

Galera Labs, LLC Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9738669

Pentaaza macrocyclic ring complexes possessing oral bioavailability

Galera Labs, LLC Β· Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9642861

Methods of treating oral mucositis

Galera Labs, LLC Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9353069

Super-oxide dismutase mimetics

Galera Labs, LLC Β· Granted Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9198893

Combination antitumor therapy

Galera Labs, LLC Β· Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9149483

Methods for treatment of diseases

Galera Labs, LLC Β· Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9150837

Polyethylene glycolated superoxide dismutase mimetics

Galera Labs, LLC Β· Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8486928

Super-oxide dismutase mimetics

Galera Therapeutics, LLC Β· Granted Tue Jul 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8217166

Polyethylene glycolated superoxide dismutase mimetics

Galera Therapeutics, LLC Β· Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted